The University of Southern California (USC) has received a prestigious $56.8 million Clinical and Translational Science Award from the National Institutes of Health (NIH) to support and promote scientific discoveries and their application in real-life settings to health and health care. The CTSA will have an important focus on health issues of people living in densely populated urban environments.
The award, which will be distributed over the next five years, was given to the USC-based Los Angeles Basin Clinical and Translational Science Institute (CTSI). CTSI was established in 2006 to connect basic scientists to clinical and community researchers and practitioners with a goal of accelerating the translation of laboratory discoveries into practice. Principal investigator is Thomas A. Buchanan, M.D., director of the Los Angeles Basin CTSI, and associate dean for clinical research at the Keck School of Medicine of USC.
"We congratulate principal investigator Dr. Tom Buchanan and the highly interdisciplinary USC team for winning this award," said Carmen A. Puliafito, M.D., M.B.A., dean of the Keck School of Medicine. "An extraordinarily strong grant application resulted in USC receiving the first Clinical and Translational Science Award in Los Angeles." The application received a score of 12 on a scale of 10 to 90 (10 is a perfect score).
Faculty from eight USC schools and Childrens Hospital Los Angeles will partner with Kaiser Permanente Southern California, the Los Angeles County departments of Health Services and Mental Health, the Community Clinic Association of Los Angeles County, and more than 30 community health organizations in greater Los Angeles to address the specific needs of the urban and diverse patient populations found in USC's backyard of downtown Los Angeles.
"We positioned our CTSI as not only an institute focused on health research, but also as a partnership among some of the largest providers of health ca
|Contact: Leslie Ridgeway|
University of Southern California